{
  "num_tested_probands": 1,
  "num_positive_het_probands": 0,
  "positive_phenotypes": [
    "infantile-onset, Levodopa-responsive Parkinsonism"
  ],
  "num_compound_or_double_hets": 1,
  "explanation": {
    "num_tested_probands": [
      "EXPLICIT: 'The patient, following informed and written consent, under the protocol 76-HG-0238...'",
      "INFERRED: Mention of 'the patient' suggests a single individual being studied."
    ],
    "num_positive_het_probands": [
      "EXPLICIT: None",
      "INFERRED: The text does not explicitly state the number of heterozygous probands, but it mentions that the patient has compound heterozygous mutations in WARS2 (p.Trp13Gly, p.Ser228Trp). This suggests that there may be other individuals with similar mutations, but the exact number is not specified."
    ],
    "positive_phenotypes": [
      "EXPLICIT: 'infantile-onset, Levodopa-responsive Parkinsonism'",
      "INFERRED: The text mentions that the patient has a form of autosomal recessive intellectual disability and a syndrome of severe infantile-onset leukoencephalopathy associated with mutations in WARS2. However, it does not explicitly state which phenotype is being studied."
    ],
    "num_compound_or_double_hets": [
      "EXPLICIT: 'compound heterozygous for... p.Trp13Gly, p.Ser228Trp'",
      "INFERRED: The text mentions that the patient has compound heterozygous mutations in WARS2, but it does not specify how many individuals have similar mutations."
    ]
  }
}